{
    "2018-10-04": [
        [
            {
                "time": "",
                "original_text": "乐普医疗股票分析：肿瘤免疫治疗布局高瞻远瞩，有望成为未来业绩重要驱动力",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "肿瘤免疫治疗",
                        "布局",
                        "未来业绩",
                        "驱动"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}